Clinical Trials Directory

Trials / Completed

CompletedNCT01364623

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Acerus Pharmaceuticals Corporation · Industry
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to assess the bioavailability of total testosterone through pharmacokinetic profiles obtained following (a) single administration of three doses of TBS-2 b) multiple administration TBS-2. In addition, assessing the bioavailability of free testosterone, dihydrotestosterone, SHBG and estradiol through pharmacokinetic profiles was also conducted.

Detailed description

This is a 2 Period study that requires overnight stays in clinic. Blood samples are required at all visits including sampling at predefined time periods during the overnight stays. Period I Subjects were checked-in on Day 1 Period I to start their baseline testosterone measurement (dependant on menstrual cycle, preferably within 48hr of start of the menstrual cycle). They remained institutionalized until Day 4 morning, and were checked out after the 48 hour blood draw and study close-out for those that did not continue with Period II. Period II (Multi-Dose) At the end of Period 1, a total of 8 subjects sampled from these 3 cohorts, who were willing and able to continue with the multiple-dose portion of the study were selected to participate in Period 2. Subjects were institutionalized starting on Day 1 of Visit 3 until Day 5 morning of Visit 3, and were checked out after the 48 hour blood draw and study close-out.

Conditions

Interventions

TypeNameDescription
DRUGLow dose testosterone nasal gel, single doseLow dose testosterone nasal gel, single dose
DRUGMedium dose testosterone nasal gel, single doseMedium dose testosterone nasal gel, single dose
DRUGHigh dose testosterone nasal gel, single doseHigh dose testosterone nasal gel, single dose
DRUGMedium dose testosterone nasal gel, multiple doseMedium dose testosterone nasal gel, multiple dose

Timeline

Start date
2011-09-01
Primary completion
2012-01-01
Completion
2012-02-01
First posted
2011-06-02
Last updated
2019-10-16
Results posted
2019-09-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01364623. Inclusion in this directory is not an endorsement.